Annie Mitsak is an investment professional at Cure Ventures. She has experience in academic licensing and venture investing within the biotechnology sector.
At firms with a similar stage, sector and check size.
One email when Annie's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAnnie Mitsak is an investment professional at Cure Ventures. She has experience in academic licensing and venture investing within the biotechnology sector.
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Annie in the subject. A warm intro from a founder Cure Ventures backed works better.
Associate Licensing Officer at MIT’s Technology Licensing Office; independent management consultant at Nelsen Biomedical; Omega Funds.
Last updated 2026-10-15. Is this you? Ask for a correction.